JP2016537652A5 - - Google Patents

Download PDF

Info

Publication number
JP2016537652A5
JP2016537652A5 JP2016552704A JP2016552704A JP2016537652A5 JP 2016537652 A5 JP2016537652 A5 JP 2016537652A5 JP 2016552704 A JP2016552704 A JP 2016552704A JP 2016552704 A JP2016552704 A JP 2016552704A JP 2016537652 A5 JP2016537652 A5 JP 2016537652A5
Authority
JP
Japan
Prior art keywords
biomarkers
expression
binding
sample
pancreatic cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016552704A
Other languages
English (en)
Japanese (ja)
Other versions
JP6600637B2 (ja
JP2016537652A (ja
Filing date
Publication date
Priority claimed from GBGB1319878.3A external-priority patent/GB201319878D0/en
Application filed filed Critical
Publication of JP2016537652A publication Critical patent/JP2016537652A/ja
Publication of JP2016537652A5 publication Critical patent/JP2016537652A5/ja
Application granted granted Critical
Publication of JP6600637B2 publication Critical patent/JP6600637B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016552704A 2013-11-11 2014-11-11 膵臓がんを決定するための方法、アレイおよびそれらの使用 Expired - Fee Related JP6600637B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1319878.3 2013-11-11
GBGB1319878.3A GB201319878D0 (en) 2013-11-11 2013-11-11 Method, Array and use thereof
PCT/GB2014/053340 WO2015067969A2 (en) 2013-11-11 2014-11-11 Method, array and use thereof

Publications (3)

Publication Number Publication Date
JP2016537652A JP2016537652A (ja) 2016-12-01
JP2016537652A5 true JP2016537652A5 (enExample) 2017-12-07
JP6600637B2 JP6600637B2 (ja) 2019-10-30

Family

ID=49818441

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016552704A Expired - Fee Related JP6600637B2 (ja) 2013-11-11 2014-11-11 膵臓がんを決定するための方法、アレイおよびそれらの使用

Country Status (12)

Country Link
US (3) US20160252513A1 (enExample)
EP (1) EP3069143B1 (enExample)
JP (1) JP6600637B2 (enExample)
KR (1) KR102240473B1 (enExample)
CN (1) CN105917230B (enExample)
AU (1) AU2014345484B2 (enExample)
BR (1) BR112016010510A2 (enExample)
CA (1) CA2930211A1 (enExample)
ES (1) ES2704888T3 (enExample)
GB (1) GB201319878D0 (enExample)
MX (1) MX2016006125A (enExample)
WO (1) WO2015067969A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008117067A2 (en) 2007-03-27 2008-10-02 Carl Arne Krister Borrebaeck Protein signature/markers for the detection of adenocarcinoma
GB201014837D0 (en) 2010-09-07 2010-10-20 Immunovia Ab Biomarker signatures and uses thereof
GB201103726D0 (en) 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
CN105021825B (zh) * 2015-07-09 2016-08-17 陈勇 一种检测胰腺癌相关多肽dap44的elisa试剂盒
GB201516801D0 (en) 2015-09-22 2015-11-04 Immunovia Ab Method, array and use thereof
GB201608192D0 (en) * 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
GB201609950D0 (en) * 2016-06-07 2016-07-20 Immunovia Ab Biomarkers signatures and uses thereof
GB201609951D0 (en) * 2016-06-07 2016-07-20 Immunovia Ab Biomarkers signatures and uses thereof
EP4053557A1 (en) * 2016-11-24 2022-09-07 Huvet Bio, Inc. Il-29 as a marker for a pancreatic disease
GB201701572D0 (en) 2017-01-31 2017-03-15 Immunovia Ab Methods, arrays and uses thereof
KR102536314B1 (ko) * 2018-05-23 2023-05-25 주식회사 휴벳바이오 질환의 진단용 조성물
US11487739B2 (en) * 2019-02-19 2022-11-01 Nasdaq, Inc. System and methods for data model detection and surveillance
CA3138991A1 (en) * 2019-05-02 2020-11-05 Ligandal, Inc. Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents
WO2020235943A1 (ko) * 2019-05-21 2020-11-26 (주)아큐레시스바이오 암의 진단용 조성물
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
KR102226826B1 (ko) * 2020-08-06 2021-03-11 주식회사 휴벳바이오 버피 코트 시료에 사용하기 위한 췌장암 진단용 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12586T1 (de) 1980-05-02 1985-04-15 Edward P Davis Beinentlastungsgeraet.
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
US6727066B2 (en) * 2000-07-28 2004-04-27 Incyte Corporation Genes expressed in treated human C3A liver cell cultures
CN1659287A (zh) * 2002-04-05 2005-08-24 美国政府健康及人类服务部 诊断肝癌转移或发病可能性及鉴定治疗靶点的方法
JP4679149B2 (ja) * 2002-09-30 2011-04-27 オンコセラピー・サイエンス株式会社 ヒト膵癌に関連する遺伝子およびポリペプチド
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof
US7217807B2 (en) * 2002-11-26 2007-05-15 Rosetta Genomics Ltd Bioinformatically detectable group of novel HIV regulatory genes and uses thereof
KR20060041205A (ko) * 2003-07-01 2006-05-11 이뮤노메딕스, 인코오포레이티드 양특이성 항체들의 다가 담체들
BR122018073034B1 (pt) * 2004-05-28 2021-10-13 Agensys, Inc Anticorpos e moléculas relacionadas que se ligam à proteínas de psca
US8383357B2 (en) * 2005-03-16 2013-02-26 OSI Pharmaceuticals, LLC Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
CA2604844A1 (en) * 2005-04-07 2006-10-19 Novartis Vaccines And Diagnostics, Inc. Cancer-related genes
JP2007051880A (ja) * 2005-08-15 2007-03-01 Tokyo Univ Of Science 膵臓癌の検出方法、膵臓癌の診断キット
NZ593226A (en) * 2006-01-11 2012-10-26 Genomic Health Inc Gene expression markers (efnb2) for colorectal cancer prognosis
WO2008117067A2 (en) * 2007-03-27 2008-10-02 Carl Arne Krister Borrebaeck Protein signature/markers for the detection of adenocarcinoma
US8664358B2 (en) * 2007-06-29 2014-03-04 Vermillion, Inc. Predictive markers for ovarian cancer
EP2271941B1 (en) * 2008-03-07 2012-08-08 OSI Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
GB0815846D0 (en) * 2008-09-01 2008-10-08 Immunovia Ab diagnosis, prognosis and imaging of disease
CN108181457B (zh) * 2009-03-12 2021-03-30 癌症预防和治疗有限公司 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒
WO2011039289A1 (de) * 2009-09-29 2011-04-07 Protagen Ag Markersequenzen für pankreaskrebserkrankungen, pankreaskarzinom und deren verwendung
MY185582A (en) * 2010-01-07 2021-05-24 Malaysian Palm Oil Board Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atheroslerosis and cardiovascular disease
CN102279264A (zh) * 2010-06-09 2011-12-14 李彬 48种恶性肿瘤标志物抗体芯片的制备方法
CN106011233A (zh) * 2010-08-13 2016-10-12 莫尔豪斯医学院 中风的生物标记
GB201103726D0 (en) * 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
WO2012139628A1 (en) * 2011-04-11 2012-10-18 Lykera Biomed Sa Coding polypurine hairpins for the treatment of cancer

Similar Documents

Publication Publication Date Title
JP2016537652A5 (enExample)
Bader et al. MS-based proteomics of body fluids: the end of the beginning
Welton et al. Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array
de Hoog et al. RNA and RNA binding proteins participate in early stages of cell spreading through spreading initiation centers
Zhou et al. Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery
JP2019516981A5 (enExample)
US12205677B2 (en) System and method for analysis of biological data
CN108034724B (zh) 用于预测结直肠癌预后及死亡风险的环状rna分子标记物及其应用
JP2013541697A5 (enExample)
JP2010522875A5 (enExample)
CN107110867A (zh) 用于肝癌诊断的生物标记物及其用途
Nie et al. Deep-dive targeted quantification for ultrasensitive analysis of proteins in nondepleted human blood plasma/serum and tissues
Schwenk et al. Comparative protein profiling of serum and plasma using an antibody suspension bead array approach
JP2016519767A5 (enExample)
Zeng et al. Highly sensitive and specific graphene oxide-based FRET aptasensor for quantitative detection of human soluble growth stimulating gene protein 2
KR20230074025A (ko) 세포 노화 바이오 마커 ac008012.1, cldn11, hmgn2, chaf1b 또는 klhl13, 및 이를 이용한 세놀리틱 약물을 스크리닝 하는 방법
CN104812914B (zh) 诊断受试者中的肝癌的方法及诊断肝癌的试剂盒
JP2017508983A (ja) サーマルシフトアッセイを使用して薬物反応の減少の指標となるバイオマーカーを識別するための方法
Percy et al. Multiplexed panel of precisely quantified salivary proteins for biomarker assessment
US20230133776A1 (en) Methods for diagnosing cancer
CN106011142A (zh) 一种特异识别psa蛋白的寡核苷酸配基p7-26的序列和应用
JP2017529074A (ja) 治療剤に対する抵抗性の診断に使用するためのＥＲＣＣ１アイソフォーム３のｍＲＮＡおよび／またはタンパク質ならびにこのｍＲＮＡおよび／またはタンパク質を使用する治療剤に対する抵抗性を診断するための方法
CN113791218B (zh) 一种用于评估超米兰标准肝癌患者肝移植后肿瘤复发风险的试剂盒
Muthelo et al. Magnetic Bead Based Proximity Extension Assay for Sensitive Protein and Extracellular Vesicles Detection
CN205539001U (zh) 检测蛋白质乙酰化水平的蛋白芯片及试剂盒